Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Allergan has announced it will establish a research and development (R&D) site in Cambridge, Massachusetts.The site will be led by Don Frail, PhD, Senior Vice President of Research and External Scientific Innovation (RESI) and Non-Clinical and...

AstraZeneca has announced a reorganization of its research and development (R&D) and commercial units and has changed some of its executive management for those areas. Under the new structure, AstraZeneca will form two R&D units: one...

Torrent Pharmaceuticals, an India-based pharmaceutical company, is expanding its voluntary recall from two lots of losartan potassium tablets USP to a total of 10 lots to the consumer level due to the detection of trace amounts of an...

Eli Lilly and Company has agreed to acquire Loxo Oncology, a Stamford, Connecticut-based biopharmaceutical company, for $235.00 per share in cash, or approximately $8.0 billion. Loxo Oncology is focused on the development and commercialization of...

Teva Pharmaceutical Industries reports that it has resolved its ongoing dispute with Amgen over Teva’s generic cinacalcet HCl product. Teva and Amgen have been involved in patent-infringement litigation, and Teva recently received approval for, and...

Akorn, a Lake Forest, Illinois-headquartered specialty generic pharmaceutical company, named Douglas S. Boothe as President and Chief Executive Officer (CEO), effective January 1, 2019. Most recently, Boothe served as the President of the generics...

Mallinckrodt, a specialty pharmaceutical company, plans to spin off a new company consisting of its specialty generics/active pharmaceutical ingredients (API) businesses and Amitiza (lubiprostone), a constipation drug to Mallinckrodt shareholders,...